Nomura Holdings’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History

Nomura Holdings’s Portfolio BIOT Stock Details BIOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-400,000	Closed	-$4.04M	–	1948
2022 Q4	$4.04M	Hold	400,000	–	–	0.02%	552
2022 Q3	$3.97M	Hold	400,000	–	–	0.02%	624
2022 Q2	$3.95M	Hold	400,000	–	–	0.01%	622
2022 Q1	$3.94M	Hold	400,000	–	–	0.01%	704
2021 Q4	$3.94M	Hold	400,000	–	–	0.01%	783
2021 Q3	$3.89M	Hold	400,000	–	–	0.01%	710
2021 Q2	$3.86M	Buy	+400,000	New	+$3.89M	0.01%	654

Nomura Holdings's BIOT Position: Q1 2023 in Review

Nomura Holdings sold out of Biotech Acquisition Company Class A Ordinary Shares (BIOT) in Q1 2023, closing a stake of 400,000 shares — an estimated $4.04M sold.

Nomura Holdings first reported a position in BIOT in Q2 2021 and held it in 7 quarters. The position peaked at $4.04M in Q4 2022. 0 funds tracked by Wall St. Rank hold BIOT as of Q1 2023.

Nomura Holdings reported no remaining Biotech Acquisition Company Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Nomura Holdings sold 400,000 Biotech Acquisition Company Class A Ordinary Shares shares in Q1 2023, an estimated $4.04M.
Nomura Holdings first reported a position in Biotech Acquisition Company Class A Ordinary Shares in Q2 2021 and held it in 7 quarters.
Nomura Holdings's Biotech Acquisition Company Class A Ordinary Shares position peaked at $4.04M in Q4 2022.
0 funds tracked by Wall St. Rank held Biotech Acquisition Company Class A Ordinary Shares as of Q1 2023.

Based on Nomura Holdings's 13F filing for Q1 2023, filed 15 May 2023.